Terplex DNA delivery system as a gene carrier
- PMID: 9487557
- DOI: 10.1023/a:1011917224044
Terplex DNA delivery system as a gene carrier
Abstract
Purpose: To characterize the physical and biochemical properties of the DNA terplex delivery system, which has previously been shown to deliver and express pSV-beta-gal plasmid efficiently in cultured smooth muscle cells (SMC) (1).
Methods: Atomic force microscopy (AFM), zeta-potential measurement (ZP), gel electrophoresis (GE), circular dichroism (CD), fluorescence quenching and 1H-NMR spectrometry were used.
Results: AFM showed that the plasmid DNA of about 600 nm long in its extended state was condensed to the size of about 100 nm by terplex formation. The DNA condensing effect of the terplex system was as good as unmodified PLL, as shown by an ethidium bromide displacement assay. Zeta-potential measurement showed that the terplex system exerts a slightly positive surface charge (+2 mV) at a 1:1:1 weight ratio of DNA:LDL:stearyl-PLL, which showed the best transfection efficiency on SMC. GE indicated that electrophoretic mobility of the terplex system decreased with increasing amounts of stearyl-PLL, indicating that the surface charge of the terplex system became more positive as more stearyl-PLL was added. Results from CD showed that there was no significant changes in tertiary structure of plasmid DNA from the terplex formation. Presence of strong hydrophobic interaction between stearyl-PLL and LDL was confirmed by 1H-NMR, where about a 30% decrease in epsilon-methylene peak of PLL backbone was observed when stearyl-PLL was mixed with LDL, but this phenomenon was not observed when unmodified PLL was used.
Conclusions: Our results indicate that the plasmid DNA, when formulated with the stearyl-PLL and LDL, forms a stable and hydrophobicity/charge balanced terplex system of optimal size for efficient cellular uptake and the DNA is still intact after the terplex formation. This information is expected to be utilized for the development of much improved transfection vectors for in vivo gene therapy.
Similar articles
-
A new non-viral DNA delivery vector: the terplex system.J Control Release. 1998 Apr 30;53(1-3):175-82. doi: 10.1016/s0168-3659(97)00251-4. J Control Release. 1998. PMID: 9741925
-
Terplex gene delivery system.Adv Genet. 2005;53:263-74. Adv Genet. 2005. PMID: 16240997 Review.
-
Terplex Gene Delivery System.Adv Genet. 2005;53PA:263-274. doi: 10.1016/S0065-2660(05)53010-4. Adv Genet. 2005. PMID: 16243067
-
Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA.Hum Gene Ther. 1999 Nov 1;10(16):2657-65. doi: 10.1089/10430349950016690. Hum Gene Ther. 1999. PMID: 10566893
-
Tailoring new gene delivery designs for specific targets.J Drug Target. 2000;8(1):1-12. doi: 10.3109/10611860009009205. J Drug Target. 2000. PMID: 10761641 Review.
Cited by
-
Functional polymers of gene delivery for treatment of myocardial infarct.J Control Release. 2014 Dec 10;195:110-9. doi: 10.1016/j.jconrel.2014.07.041. Epub 2014 Jul 27. J Control Release. 2014. PMID: 25076177 Free PMC article. Review.
-
Nucleic acid-binding properties of low-density lipoproteins: LDL as a natural gene vector.J Protein Chem. 1999 Nov;18(8):845-57. doi: 10.1023/a:1020627212272. J Protein Chem. 1999. PMID: 10839621
-
Novel water insoluble lipoparticulates for gene delivery.Pharm Res. 2002 Apr;19(4):382-90. doi: 10.1023/a:1015166806366. Pharm Res. 2002. PMID: 12033368
-
Cationic polymer based gene delivery systems.Pharm Res. 2000 Feb;17(2):113-26. doi: 10.1023/a:1007548826495. Pharm Res. 2000. PMID: 10751024 Review.
-
Corneal gene therapy: Structural and mechanistic understanding.Ocul Surf. 2023 Jul;29:279-297. doi: 10.1016/j.jtos.2023.05.007. Epub 2023 May 25. Ocul Surf. 2023. PMID: 37244594 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous